The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

TAVI adoption in Germany: onwards and upwards

EuroIntervention 2016;11:968-970. DOI: 10.4244/EIJV11I9A198

1. Galway University Hospital, Galway, Ireland; 2. McGill Healthcare Centre, Montreal, Quebec, Canada; 3. International Centre of Circulatory Health, Imperial College London, London, United Kingdom


“I am a slow walker, but I never walk back.”

Abraham Lincoln

Since Professor Alain Cribier first performed a transcatheter aortic valve implantation (TAVI) in June 20021, TAVI has emerged as a safe, effective, and widely practised intervention that has transformed the lives of hundreds of thousands of patients worldwide2 and has answered an unmet clinical need as TAVI is now the standard of care for inoperable patients and the preferred therapeutic option for high-risk patients with severe aortic stenosis3,4. Moreover, transcatheter heart valve (THV) technology has expanded well beyond Professor Cribier’s initial intentions, and is frequently ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Infrainguinal occlusions: the real challenge for the endovascular specialist